A Phase 1, Open-Label, Single-Dose, Pharmacokinetic and Safety Study of E7080 (24 mg) Administered to Subjects With Mild, Moderate, and Severe Renal Impairment and to Healthy Subjects
Clinical trial NCT02199379 · COMPLETED
Trial details
- NCT number
- NCT02199379
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2012-10-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.